FACTS ABOUT MILD COGNITIVE IMPAIRMENT TREATMENT REVEALED

Due to the fact individuals who have the APOE e4 gene variant appear to have a higher threat of great issues, the FDA suggests currently being tested for that gene variant before beginning treatment with lecanemab or donanemab.PET scans. These scans can exhibit designs of Mind action. They are able to determine irrespective of whether amyloid or ta